Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7643)
All Articles published online
|
Publishing Process of This Article
|
Jul 18, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Khullar V, Firpi RJ. Hepatitis C cirrhosis: New perspectives for diagnosis and treatment. World J Hepatol 2015; 7(14): 1843-1855 [PMID: 26207166 DOI: 10.4254/wjh.v7.i14.1843] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i14/1843.htm |
| Number | Citing Articles |
| 1 |
Yuan-Ai Tseng, Yu-Lun Ou, Jiun-Hung Geng, Chih-Wen Wang, Da-Wei Wu, Szu-Chia Chen, Po-Liang Lu. The association between alcohol, betel nut, and cigarette use with hepatitis C virus infection in Taiwan. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-50588-1
|
| 2 |
Mohamed N.M.T. Al Khayat, Job F.H. Eijsink, Maarten J. Postma, Jan C. Wilschut, Marinus van Hulst. The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands. International Journal of Environmental Research and Public Health 2020; 17(17): 6091 doi: 10.3390/ijerph17176091
|
| 3 |
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile. Personalized care approaches to hepatitis C therapy: recent advances and future directions. Expert Review of Anti-infective Therapy 2024; 22(4): 139 doi: 10.1080/14787210.2024.2328336
|
| 4 |
Stefania Notari, Massimo Tempestilli, Gabriele Fabbri, Raffaella Libertone, Andrea Antinori, Adriana Ammassari, Chiara Agrati. UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients. Journal of Chromatography B 2018; 1073: 183 doi: 10.1016/j.jchromb.2017.12.018
|
| 5 |
Marleen H. M. Hessel, Adam F. Cohen, Robert Rissmann. Sofosbuvir and daclatasvir. British Journal of Clinical Pharmacology 2016; 82(3): 878 doi: 10.1111/bcp.13011
|
| 6 |
Isabel Oriol, Laura Lladó, Marina Vila, Carme Baliellas, Fe Tubau, Núria Sabé, Joan Fabregat, Jordi Carratalà, Salvatore Gruttadauria. The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation. PLOS ONE 2016; 11(8): e0160701 doi: 10.1371/journal.pone.0160701
|
| 7 |
Maissa El-Raziky, Marwa Khairy, Ahmed Fouad, Ahmed Salama, Aisha Elsharkawy, Omnia Tantawy. Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens. Journal of Interferon & Cytokine Research 2018; 38(3): 129 doi: 10.1089/jir.2017.0137
|
| 8 |
Banny Silva Barbosa Correia, Priscila Marques Firmiano Dalle Piagge, Luísa Souza Almeida, Gabriel Henrique Ribeiro, Cristina de Souza Peixoto, Luiz Alberto Colnago, Daniel Rodrigues Cardoso. COVID-19 Metabolomics and Diagnosis. 2023; : 129 doi: 10.1007/978-3-031-15889-6_7
|
| 9 |
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and D. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
|
| 10 |
Marcello Persico, Andrea Aglitti, Michele Milella, Carmine Coppola, Vincenzo Messina, Ernesto Claar, Ivan Gentile, Fernando Sogari, Paola Pierri, Lorenzo A. Surace, Filomena Morisco, Paolo Tundo, Giuseppina Brancaccio, Gaetano Serviddio, Pietro Gatti, Antonio P. Termite, Giovan G. Di Costanzo, Benedetto Caroleo, Raffaele Cozzolongo, Nicola Coppola, Annamaria Longo, Luca Fontanella, Alessandro Federico, Valerio Rosato, Irene Terrenato, Mario Masarone. Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study. Liver International 2019; 39(10): 1852 doi: 10.1111/liv.14170
|
| 11 |
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Hepatitis C-related cirrhosis. Current status. Medicina Clínica (English Edition) 2017; 148(2): 78 doi: 10.1016/j.medcle.2016.09.035
|
| 12 |
Zain Ul Abedien, Kainat Gul, Sara Khan, Maheen Shafiq, Khizar Rahman, Muhammad Hassan Nawaz. Pathogenesis of Oncoviruses: A Systemic Review. Microbiology and Biotechnology Letters 2023; 51(2): 135 doi: 10.48022/mbl.2303.03006
|
| 13 |
Qingliang Wang, Xiaojie Li, Yaqiong Chen, Jiao Gong, Bo Hu. Classification and survival prediction in early‐stage cirrhosis by gene expression profiling. Journal of Viral Hepatitis 2023; 30(2): 116 doi: 10.1111/jvh.13769
|
| 14 |
Hung-Chang Hung, Hsien-Hua Liao, Shiuan-Chih Chen, Shih-Ming Tsao, Yuan-Ti Lee. Maintenance interferon therapy in chronic hepatitis C patients who failed initial antiviral therapy. Medicine 2019; 98(19): e15563 doi: 10.1097/MD.0000000000015563
|
| 15 |
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host. 2016; : 69 doi: 10.1128/9781555819040.ch3
|
| 16 |
Katerina Kassela, Ioannis Karakasiliotis, Stefanos Charpantidis, John Koskinas, Theodora Mylopoulou, Konstantinos Mimidis, Christoph Sarrazin, Georgios Grammatikos, Penelope Mavromara. High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis.
Journal of General Virology
2017; 98(7): 1713 doi: 10.1099/jgv.0.000851
|
| 17 |
Stefano Fagiuoli, Pierluigi Toniutto, Nicola Coppola, Domenica Daniela Ancona, Margherita Andretta, Fausto Bartolini, Fulvio Ferrante, Alessandro Lupi, Stefano Palcic, Francesca Vittoria Rizzi, Davide Re, Gema Alvarez Nieto, Candido Hernandez, Francesca Frigerio, Valentina Perrone, Luca Degli Esposti, Alessandra Mangia. Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). Therapeutics and Clinical Risk Management 2023; : 57 doi: 10.2147/TCRM.S394467
|
| 18 |
Yibin Wang, Haijun Huang, Renhua Sun, Bingyu Chen, Fang Han, Qian Li, Yin Ni, Xi Li, Jingquan Liu, Xiaozhou Mou, Yuexing Tu. Serum amyloid a induces M2b-like macrophage polarization during liver inflammation. Oncotarget 2017; 8(65): 109238 doi: 10.18632/oncotarget.22652
|
| 19 |
Jarin Prasa, Syed S. Karim, Bobby Jacob, Paul Mustacchia, Dirk Uhlmann. Hepatitis C Prevalence on the Rise but Screening at Safety Net Institutions Lagging behind. International Journal of Hepatology 2023; 2023: 1 doi: 10.1155/2023/3650746
|
| 20 |
Lidia Elbieta Sierpińska. Assessment of Health Behaviors of Patients with Hepatitis C. American Journal of Health Behavior 2022; 46(5): 586 doi: 10.5993/AJHB.46.5.9
|
| 21 |
Anna Jakubowska, Grzegorz Żuchowski, Katarzyna Kulig. Cyclic sulfates as useful tools in the asymmetric synthesis of 1-aminocyclopropane-1-carboxylic acid derivatives. Tetrahedron: Asymmetry 2015; 26(21-22): 1261 doi: 10.1016/j.tetasy.2015.09.013
|
| 22 |
Tien S Dong, Elizabeth S Aby, Jihane N Benhammou, Jenna Kawamoto, Steven-Huy Han, Folasade P May, Joseph R Pisegna. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c. World Journal of Hepatology 2018; 10(9): 612-621 doi: 10.4254/wjh.v10.i9.612
|
| 23 |
Omar T. Sims, Duong N. Truong, Kaiying Wang, Pamela A. Melton, Kasey Atim. Time to HCV Treatment Disfavors Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center. Journal of Racial and Ethnic Health Disparities 2022; 9(5): 1662 doi: 10.1007/s40615-021-01105-5
|
| 24 |
Alisa A. Petkevich, Aleksandr A. Abramov, Vadim I. Pospelov, Natalya A. Malinina, Elena I. Kuhareva, Natalya V. Mazurchik, Olga I. Tarasova. Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer. Oncotarget 2021; 12(17): 1697 doi: 10.18632/oncotarget.28036
|
| 25 |
S. Tsiomita, U. Georgopoulou, P.P. Doumba, J. Koskinas, K. Adamidis, C. Papaloukas, G. Thyphronitis. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection. Infection, Genetics and Evolution 2018; 58: 17 doi: 10.1016/j.meegid.2017.12.002
|
| 26 |
Megan Lee, Huixun Du, Daniel A. Winer, Xavier Clemente-Casares, Sue Tsai. Mechanosensing in macrophages and dendritic cells in steady-state and disease. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.1044729
|
| 27 |
VPS Punia, Nikhil Agrawal, Akash Bharti, Shaavi Mittal, Dhirender Chaudhary , Atmika Mathur, Shahzad Anwar, Aditya Chakravorty. Association of TGF-β1 Polymorphism and TGF-β1 Levels With Chronic Hepatitis C and Cirrhosis: A Systematic Review and Meta-Analysis. Cureus 2023; doi: 10.7759/cureus.41157
|
| 28 |
Eric Lawitz, Fred Poordad, Julio A. Gutierrez, Maria Beumont, Greet Beets, Ann Vandevoorde, Pieter Van Remoortere, Donghan Luo, Leen Vijgen, Veerle Van Eygen, Mohamed Gamil. Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study. Health Science Reports 2020; 3(2) doi: 10.1002/hsr2.145
|
| 29 |
Timothy J Philip, Kimberly M Crosby, Summer G Frank-Pearce, Aaron M Wendelboe, Marie Solberg, Jennifer Weakley, Mary B Williams. Factors impacting medication adherence in a birth cohort at higher risk for Hepatitis C infection. Medicine 2022; 101(50): e32354 doi: 10.1097/MD.0000000000032354
|
| 30 |
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Cirrosis por hepatitis C. Estado actual. Medicina Clínica 2017; 148(2): 78 doi: 10.1016/j.medcli.2016.09.019
|
| 31 |
Andrew R. Zareie, Prerna Dabral, Subhash C. Verma. G-Quadruplexes in the Regulation of Viral Gene Expressions and Their Impacts on Controlling Infection. Pathogens 2024; 13(1): 60 doi: 10.3390/pathogens13010060
|
| 32 |
Mahmoud A. Saleh, Mona A. Mohamed, Ahmed Shahat, Nageh K. Allam. Sensitive Determination of SARS-COV-2 and the Anti-hepatitis C Virus Agent Velpatasvir Enabled by Novel Metal–Organic Frameworks. ACS Omega 2021; 6(40): 26791 doi: 10.1021/acsomega.1c04525
|
| 33 |
Nancy Reau, Wei-Han Cheng, Qiujun Shao, Steven E. Marx, Hannah Brooks, Anthony Martinez. Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients. Infectious Diseases and Therapy 2023; 12(7): 1849 doi: 10.1007/s40121-023-00823-z
|
| 34 |
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, Esam Ibraheem Azhar. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913231
|
| 35 |
Stacey B. Prenner, Lisa B. VanWagner, Steven L. Flamm, Riad Salem, Robert J. Lewandowski, Laura Kulik. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals. Journal of Hepatology 2017; 66(6): 1173 doi: 10.1016/j.jhep.2017.01.020
|
| 36 |
Ahmed Serag, Reem M. Alnemari, Maram H. Abduljabbar, Manal E. Alosaimi, Atiah H. Almalki. Synchronous spectrofluorimetry and chemometric modeling: A synergistic approach for analyzing simeprevir and daclatasvir, with application to pharmacokinetics evaluation. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2024; 315: 124245 doi: 10.1016/j.saa.2024.124245
|
| 37 |
Esther González-Almela, Hugh Williams, Miguel A. Sanz, Luis Carrasco. The Initiation Factors eIF2, eIF2A, eIF2D, eIF4A, and eIF4G Are Not Involved in Translation Driven by Hepatitis C Virus IRES in Human Cells. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00207
|
| 38 |
Amal Kumar Dhara, Amit Kumar Nayak. Viral Infections and Antiviral Therapies. 2023; : 3 doi: 10.1016/B978-0-323-91814-5.00025-8
|